FDA grants South Texas Blood & Tissue Center first license for new process that triples shelf life of critically needed platelets
February 28, 2020 08:45 ET
|
BioBridge Global
San Antonio, Texas, Feb. 28, 2020 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration has granted the South Texas Blood & Tissue Center (STBTC) a license to use a new process shown to...
Hemoglobinopathies Market To Reach USD 13.68 Billion By 2026 | Reports And Data
November 07, 2019 12:06 ET
|
Reports and Data
New York, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Insufficient healthcare infrastructure and low levels of disease diagnosis and treatments, rising prevalence of hemoglobin disorders such as Sickle Cell...